DAFTAR PUSTAKA
1. Zubier F. Kondiloma akuminata. In: Daili FS, Makes BIN, Zubier F,
Judanarso J, editors. Infeksi menular seksual. 3rd ed. Jakarta: Balai Penerbit
Fakultas Kedokteran Universitas Indonesia; 2005.p.126-31.
2. Murtiastutik D. Kondiloma akuminata. In: Barakbah J, Lumintang H,
Martodihardjo S, editors. Buku ajar infeksi menular seksual. Surabaya:
Airlangga University Press; 2008.p.165-9.
3. Centers for Disease Control and Prevention. Sexually transmitted disease
treatment guidelines 2010. Morbidity and Mortality Weekly Report. 2010; 59:
69-78.
4. Winer RL, Koutsy LA. Genital human papillomavirus infection. In: Holmes
KK, Sparling PF, Stamm WE, Piot P. Wasserheit JN, Corey L, Cohen MS,
Watts DH, editors. Sexually transmitted disease. 4th ed. New York: McGraw
Hill; 2008.p.489-501.
5. Monk BJ, Tewari KS. The spectrum and clinical sequellae of human
papillomavirus infection. Gynecol Oncol. 2007; 107(2):6-13.
6. Steben M, Duarte-Franco E. Human papillomavrus infection: Epidemiology
and pathophysiology. Gynecol Oncol. 2007;107(2):2-5.
7. Alba A, Cararach M, Rodriquez-Cerdeira C. The human papillomavirus
(HPV) in human pathology; description, pathogenesis, oncogenic role,
epidemiology and detection technique. The Open Dermatology Journal. 2009;
3:90-102.
8. World Health Organization. Sexually transmitted infections (STIs) [internet].
2016 [cited 2016 November 15]. Available from:
http://www.who.int/mediacentre/factsheets/fs110/en/
9. Centers for Disease Control dan Prevention: Incidence, prevalence, and cost
of sexually transmitted infections in the United State [internet]. 2013 [cited
http://www.cdc.gov/std/stats/STI-10.Indriatmi W, Zubier F, Daili SF, Nilasari H. Lesi jinak infeksi Human
Papillomavirus di daerah anogenital. In: Andrijono, Indriatmi W. Infeksi
human papillomavirus. Jakarta: Balai Penerbit Fakultas Kedokteran
Universitas Indonesia;2013.p.47-61.
11.Nelwa SR, Niode NJ, Kapantouw MG. Profil kondiloma akuminata di
poliklinik kulit dan kelamin RSUP Prof. DR. R.D. Kandou Manado periode
Januari 2012-Desember 2012 [Skripsi]. Manado: Universitas Sam Ratulangi;
2014.
12.Silitonga, Tetraulina J. Gambaran infeksi menular seksual di RSUP H. Adam
Malik Medan tahun 2009 [internet]. 2011 [cited 2015 November 10].
Available from: http://repository.usu.ac.id/bitstream/ 123456789/25065/7/
Cover.pdf
13.Aswar A. Karakteristik pasien kondiloma akuminata Di RSUP Haji Adam
Malik Medan Periode 1 Januari 2008 - 31 Desember 2011 [Skripsi]. Medan:
Universitas Sumatera Utara; 2012.
14.Benedick PI. Gambaran Karakteristik infeksi menular seksual (IMS) Di
RSUD Dr. Pirngadi Medan Pada Tahun 2012 [Skripsi]. Medan: Universitas
Sumatera Utara; 2013.
15.Lumintang H, Murniastutik D. The profile of new patient condyloma
accuminata at departement dermatovenereology Dr. Soetomo Hospital
Surabaya in 2008-2009 [internet]. 2011 [cited 2015 November 10]. Available
from journal.unair.ac.id.
16.Stanley MA. Immune responses to human papillomaviruses. Indian J Med
Res. 2009;130:266-76.
17.Scott M, Nakagawa M, Moscick AB. Cell-mediated immune response to
human papillomavirus infection. Clin Diagn Lab Immunol. 2001;8(2):209-20.
18.Leto MGP, Santor Jr GF, Poro AM, Tomimori J. Human papillomavirus
infection: etiopathogenesis, molecular biology and clinical manifestations. An
19.Williams IR, Kupper TS. Cytokines. In: Wolff K, Goldsmith LA, Katz SI,
Gilchrest BA, Paller AS, Leffel DJ, editors. Fitzpatrick’s dermatology in
general medicine. 8th ed. New York: McGraw Hill; 2012.p.126-41.
20.Shi Y, Yang J, Yang W. Mechanistic investigation of immunosuppression in
patients with condyloma acuminata. Molecular Medicine Reports.
2013;8:480-6.
21.Nambudiri VE, Mutyambizi K, Walls AC, Fisher DC, Bleday R, Saavedra
AP. Successful treatment of perianal giant condyloma acuminatum in an
immunocompromised host with systemic interleukin 2 and topical cidofovir.
JAMA Dermatology. 2013; 149(9):1068-70.
22.Yi-xuan W, Huan F. CO2 laser combined with interleukin-2 in treatment of
female condyloma acuminatum. Chinese Journal of New Drugs and Clinical
Remedies [internet]. 2002 [cited 2015 November 15];12. Available from:
http://en.cnki.com.cn/Article_en/CJFDTOTAL-XYYL200212003.htm
23.Qifeng Q. Serum interleukin-2 and soluble interleukin-2 receptor level in
patient with condyloma acuminatum detected by ELISA. The Chinese Journal
of Dermatovenerelology [internet]. 1996 [cited 2015 November 15];03.
Available from: http://en.cnki.com.cn/CJFD_en_New/Detail.ashx?t=e&url=/
Article_en/CJFDTOTAL-ZBFX603.013.htm
24.Yating T, Zhixiang L, Changzheng H, Houjun L. The study on expression of
interleukin-2 gene in lesion condyloma acuminatum. Chinese Journal of
Histochemistry and Cytochemistry [internet]. 1999 [cited 2015 November
13];04. Available from:
http://en.cnki.com.cn/Article_en/CJFDTOTAL-GGZZ199904012.htm
25.Yating T, Nengxiang L, Zhix-ang L. Levels of serum IFN-γ, IL-2 and IL-4 in
condyloma acuminata with different courses. Central China Medical Journal.
2003; 27(2):58-9.
26.Guangwen Y, Jianbin Y, Fucheng H, et al. Detection of T-lymphocyte
[internet]. 2001 [cited 2015 November 18];01. Available from:
http://en.cnki.com.cn/Article_en/CJFDTOTAL-MALA200101010.htm
27.Zhou-jin Yi, Xiong-wei WU. Study on serum level of IL-2 and IFN-r in
patients with condyloma acuminate. Practical Preventive Medicine [internet].
2002 [cited 2015 November 15];02. Available from:
http://en.cnki.com.cn/Article_en/CJFDTOTAL-SYYY200706109.htm
28.Ning L. Clinical significance of measurement of serum IL2, IL6 and TNFα
levels before and after treatment in patients with condyloma acuminatum.
Labeled Immunoassays and Clinical Medicine. 2006; 13(3): 155-6.
29.Ji Feng S, Chun Yan Y, Qun GU, H ong Shu et al. Change in cytokine in
condyloma acuminatum and verruca vulgaris patients. Journal of the Fourth
Military Medical University. 2002; 17:1615-6.
30.Centre for Disease Control and Prevention. Sexually transmitted disease
treatment guidelines 2015. Morbidity and Mortality Weekly Report.
2015;64:84-61.
31.Hakim L. Biologi dan patogenesis human papilomavirus. PKB “New
perspective of sexually transmitted infection problems. Surabaya;
2010.p.164-80.
32.Man S. Human cellular immune responses against human papilloma viruses in
cervical neoplasia. Expert Reviews in Molecular Medicine. 1998; 1998:1-18.
33.Sanclemente G, Gill DK. Human papillomavirus molecular biology and
pathogenesis. J Eur Acad Dermatol Venereol. 2002; 16(3):231-40.
34.Conway MJ, Meyers C. Replication and assembly of Human
papillomaviruses. J Dent Res. 2009; 88(4): 307-17.
35.Kirnbauer R, Lenz P. Human papillomavirus. In: Bolognia JL, Jorizzo JL,
Schaffer JV. Dermatology. 3rd ed. UK: Elsevier Saunders. 2012.p.1303-19
36.Androphy EJ, Kirnbauer R. Human papillomavirus. In: Wolff K, Goldsmith
LA, Katz SI, Gilchrest BA, Paller AS, Leffel DJ, editors. Fitzpatrick’s
dermatology in general medicine. 8th ed. New York: McGraw Hill;
37.Satyaprakash A, Mansur C. Human papillomavirus. In: Mucocutaneous
manifestations of viral disease. 2nd ed. UK: Informa
Healthcare;2010.p.207-52.
38.Castellsague X et al. Male circumcision, penile human papillomavirus
infection, and cervical cancer in female partners. N Engl J Med. 2002;
346(15):1105-12.
39.Winer RL et al. Condom use and the risk of genital human papillomavirus
infection in young women. N Eng J Med. 2006; 354(25):2645-54.
40.Kirnbauer R dkk. Papillomavirus L1 major capsid protein self-assembles into
virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A.
1992; 89(24):12180-4.
41.Mariani L, Venuti A. HPV vaccine: an overview of immune response, clinical
protection and new approaches for the future. Journal of translational
medicine. 2010; 105:1-8.
42.Carter JR, Ding Z, Rose BR. HPV infection and cervical disease: A review.
Australian and New Zealand journal of obstetrics and gynaecology. 2011;
5(2):103-08.
43.Heideman DAM, Snijders PJF, Berkhof J, Verheijen RHM, Helmerhorst TJM,
Meijer CJLM. Vaccination against HPV: indications for women and the
impact on cervical screening programme. BJOG. 2008; 115(8):938-46.
44.Silling S, Wieland U, Werner M, Pfister H, Potthoff A, Kreuter A. Resolution
of novel human papillomavirus induced warts after HPV vaccination.
Emerging Infectious Diseases. 2014; 20(1):142-5.
45.Kresno SB. Imunologi: Diagnosis dan prosedur laboratorium. Edisi ke-4.
Jakarta: Balai Penerbit Fakultas Kedokteran Universitas Indonesia,
2001.p.63-80.
46.Morgan MC, Rashid R, Tyring SK. Cutaneous resistance to viral infections.
In: Mucocutaneous manifestations of viral disease. 2nd ed. UK: Informa
47.Chayachinda C, Boriboohirunsarn D, Thamkhanto M, Nuengton C,
Chalermchockcharoenkit A. Number of extend anogenital warts is associated
with the occurrence of abnormal cervical cytology. Asian Pacific Journal of
Cancer Prevention. 2014; 15: 1177-80.
48.Aubin F, Pretet JL, Jacquard AC, Saunier M, Careopino X, Jaroud F, et al.
Human papillomavirus genotype distribution in eksternal acuminata
condylomata: A large French National Study (EDiTH IV). Clinical Infection
Disease. 2008; 47: 610-5.
49.Adriman Z. Karakteristik pasien kutil kelamin di RSUD Dr. Pirngadi Medan
2010-2012 [Tesis]. Medan: Universitas Sumatera Utara; 2014.
50.Aprilianingrum F. Faktor risiko kondiloma akuminata pada pekerja seks
komersial di Semarang [Tesis]. Semarang: Universitas Diponegoro; 2006.
51.Hidayat T. Deteksi Human papilloma virus tipe 6 dan 11 pada lesi dan peri
lesi kondiloma akuminatum dengan polymerase chain reaction [Tesis].
Padang: Universitas Andalas; 2012.
52.Hidayati A. Gambaran histopatologi pada berbagai lesi kondiloma akuminata
[Tesis]. Medan: Universitas Sumatera Utara; 2016.
53.Kliewer EV, Demers AA, Elliott L, Lotocki R, Butler JRG, Brisson M.
Twenty-year trends in the incidence and prevalence of diagnosed anogenital
warts in Canada. J Sexually Transmitted Disease. 2009; 36(6):380-6.
54.Ramenzanpour A, Fallah R. Genital warts in North-West of Iran. World
Applied Sciences Journal. 2012; 18(10): 1326-8.
55.Soori T, Hallaji Z, Neejad EN. Genital warts in 250 Iranian patients and their
high risk sexual behaviors.Arc Iran Med.2013; 16 : 518-20.
56.Murugesh SB, Sugareddy , Raghhunath S. Pattern of sexually transmitted
diseases at Davangere.Indian J sex Transm Dis. 2004;25:9-12.
57.Israita P, Lumintang H, Murtiastutik D. Profil penderita baru kondiloma
akuminata di Divisi Penyakit Menular Seksual URJ Kesehatan Kulit dan
Kelamin RSUD Dr. Soetomo Surabaya periode 2006-2008. Berkala Ilmu
58.Aldiano R, Herroda A, Yolanda F, et al. Pasien kutil kelamin di Poliklinik
Divisi Infeksi Menular Seksual Departemen/UPF Ilmu Kesehatan Kulit dan
Kelamin RS.DR. Hasan Sadikin Bandung Periode tahun 2007-2011. In:
Julianto I, Mawardi P, editor. Buku Kumpulan Makalah Lengkap I PIT XII
PERDOSKI; 2012 Juni 21-23; Solo; 2012.p.248-54.
59.Lasari HH. Gambaran epidemiologi penyakit menular seksual di Poliklinik
kulit dan kelamin RSUP Wahidin Sudirohusodo tahun 2009-Juni 2011
[Skripsi]. Makasar: Universitas Hasanuddin; 2014.
60.Kleiner G, Maruzzi A, Zanin V, Monosta L, Zauli G. Cytokine levels in the
serum of healthy subjects. Hindawi Publishing Corporation. 2013; 1-6.
61.Giron-Gonzales JA, Moral FJ, Elvira J, Garcia-Gil D, Guerrero F, Gavilan I,
Escobar L. Consistent production of a higher TH1:TH2 cytokine ratio by
stimulated T cells in men compared with women. Eur J Endocrinol. 2000;
